JAMES HOUSER: Open Payments
NPI 1063188324 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 45 payments from 22 companies in 2025. Trend: 2023 $512 · 2024 $466 · 2025 $936
Food & beverage: $837Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $181 |
| Exelixis Inc. | 6 | $141 |
| PFIZER INC. | 2 | $51 |
| Incyte Corporation | 3 | $51 |
| Eisai Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| GENZYME CORPORATION | 3 | $47 |
| Janssen Biotech, Inc. | 2 | $39 |
| ARRAY BIOPHARMA INC | 2 | $35 |
| Iovance Biotherapeutics, Inc. | 2 | $34 |
Products named: ENHERTU, Lenvima, KEYTRUDA, SARCLISA, CABOMETYX, RYBREVANT, BRAFTOVI, Amtagvi.
Industry payments across GA — which companies pay providers there.
